Cancer Research UK uses ctDNA profiling to stratify patients for early stage clinical trials

Cancer Research UK researchers used blood-based ctDNA profiling to match cancer patients with early stage clinical trials, reporting a preliminary efficiency of recruiting to a matched therapy of 11%. The researchers suggest

Read the full 320 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE